Skip to main content
Fig. 1 | BMC Musculoskeletal Disorders

Fig. 1

From: The hsa-miR-181a-5p reduces oxidation resistance by controlling SECISBP2 in osteoarthritis

Fig. 1

Both hsa-miR-181a-5p and SBP2 are regulated by IL-1β in chondrocytes. a The expression of hsa-miRNA-181a-5p, SBP2, GPX1 and MMP13 after treatment with 10 ng/ml IL-1β for 0 (as control), 6, 12, 24 and 48 h in SW1353 cells. (n = 3, 3). b The expression of SBP2, GPX1 and MMP13 after treatment with 10 ng/ml IL-1β for 0 (as control), 6, 12, 24 and 48 h in SW1353 cells. c The expression of hsa-miRNA-181a-5p and SBP2 after treatment with 0 (as control), 1, 5, 10 and 20 ng/ml IL-1β for 12 h in SW1353 cells. (n = 3, 3). The data are expressed as the mean ± SEM; *, ** and *** indicate P < 0.05, 0.01 and 0.001, respectively

Back to article page